NEW YORK, Nov. 6, 2017 /PRNewswire/ --
Read the full report: https://www.reportlinker.com/p05178765Gastro-oesophageal reflux disease (GORD) is a common disorder of the upper gastrointestinal tract. According to the most recent definition, it is a condition occurring when reflux of gastric contents causes troublesome symptoms and/or complications. Based on endoscopy findings, the disease is broadly classified into two subtypes: demonstrating oesophageal mucosal damage (Erosive Reflux Disease, ERD) or no mucosal damage (Non-Erosive Reflux Disease, NERD). Injury to the oesophagus that may be associated with GORD is due to reflux of gastric acid and pepsin, but also bile in the case of duodenogastric reflux.This report provides the current prevalent population for GORD across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Norway, Sweden, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.Providing a value-added level of insight from the analysis team at Black Swan, the two subtypes of the disease (ERD and NERD), as well as several of the main symptoms and co-morbidities of GORD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.Main symptoms and co-morbidities for GORD include:• Globus• Non-cardiac chest pain• Asthma• Dysphagia• Dyspepsia• Chronic coughThis report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.Reason to buy• Able to quantify patient populations in global GORD market to target the development of future products, pricing strategies and launch plans.• Gain further insight into the prevalence of the subdivided types of GORD and identify patient segments with high potential.• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.• Provide a level of understanding on the impact from specific co-morbid conditions on GORD prevalent population.• Identify sub-populations within GORD which require treatment.• Gain an understanding of the specific markets that have the largest number of GORD patients.Read the full report: https://www.reportlinker.com/p05178765 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
Read the full report: https://www.reportlinker.com/p05178765Gastro-oesophageal reflux disease (GORD) is a common disorder of the upper gastrointestinal tract. According to the most recent definition, it is a condition occurring when reflux of gastric contents causes troublesome symptoms and/or complications. Based on endoscopy findings, the disease is broadly classified into two subtypes: demonstrating oesophageal mucosal damage (Erosive Reflux Disease, ERD) or no mucosal damage (Non-Erosive Reflux Disease, NERD). Injury to the oesophagus that may be associated with GORD is due to reflux of gastric acid and pepsin, but also bile in the case of duodenogastric reflux.This report provides the current prevalent population for GORD across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Norway, Sweden, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.Providing a value-added level of insight from the analysis team at Black Swan, the two subtypes of the disease (ERD and NERD), as well as several of the main symptoms and co-morbidities of GORD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.Main symptoms and co-morbidities for GORD include:• Globus• Non-cardiac chest pain• Asthma• Dysphagia• Dyspepsia• Chronic coughThis report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.Reason to buy• Able to quantify patient populations in global GORD market to target the development of future products, pricing strategies and launch plans.• Gain further insight into the prevalence of the subdivided types of GORD and identify patient segments with high potential.• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.• Provide a level of understanding on the impact from specific co-morbid conditions on GORD prevalent population.• Identify sub-populations within GORD which require treatment.• Gain an understanding of the specific markets that have the largest number of GORD patients.Read the full report: https://www.reportlinker.com/p05178765 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/epiomic-epidemiology-series-gastro-oesophageal-reflux-disease-forecast-in-19-major-markets-2017-2027-300550648.html
SOURCE Reportlinker
